Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.16 USD | -0.96% | -7.23% | -55.81% |
03/04 | Stifel Cuts Price Target on Verve Therapeutics to $40 From $56, Maintains Buy Rating | MT |
02/04 | Sector Update: Health Care Stocks Slide Late Afternoon | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- VERV Stock
- Revisions Verve Therapeutics, Inc.